Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers

Author： Bao Li Sakaguchi Hideki Fujimoto Jiro Tamaya Teruhiko

ISSN： 1021-7770

Source： Journal of Biomedical Science, Vol.14, Iss.3, 2007-05, pp. : 373-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of Expression of ETS-1 Related to Angiogenesis in Metastatic Lesions of Ovarian Cancers

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 420-428

Karger

Access to resources Recommend Favorite

Clinical Implications of the Expression of Estrogen Receptor-α and -β in Primary and Metastatic Lesions of Uterine Endometrial Cancers

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 269-277

Karger

Access to resources Recommend Favorite

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Gastric and Intestinal Phenotypic Marker Expression in Gastric Carcinomas and Its Prognostic Significance: Immunohistochemical Analysis of 136 Lesions

Oncology, Vol. 61, Iss. 3, 2001-09 ,pp. : 212-220

Karger

Access to resources Recommend Favorite

Prognostic Factors in Metastatic Malignant Melanoma

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 59-64

Karger

Access to resources Recommend Favorite